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Abstract
Small regions called protein transduction domains (PTDs), identified in cellular and viral proteins, have been reported to
efficiently cross biological membranes. Here we show that the structural Gag protein of the prototypic foamy virus (PFV) is
apparently able to move from cell to cell and to transport the green fluorescent protein (GFP) from few transfected cells to
the nuclei of the entire monolayer. Deletion studies showed that this property lies within the second glycine/arginine (GRII)
box in the C-terminus of the protein. We also found that uptake and nuclear accumulation of Gag GRII expressed as GFP-
fusion protein in recipient cells was observed only following methanol fixation, but never in living cells or when cells were
fixed with glutaraldehyde or treated with trichloroacetic acid prior to methanol fixation. Absence of intercellular spreading
in vivo was further confirmed using a sensitive luciferase activity assay based on transactivation of the PFV long terminal
repeats. Thus, we conclude that intercellular spreading of PFV Gag represents an artificial diffusion event occurring during
cell fixation, followed by nuclear retention mediated by the chromatin-binding sequence within the Gag GRII box. In light of
these results, we advise caution before defining a peptide as PTD on the basis of intercellular spreading observed by
fluorescence microscopy.
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Introduction
Foamy viruses (FVs) are complex animal retroviruses, which
encode for structural (Gag, Env), enzymatic (Pol) and regulatory
proteins such as the transactivator protein, Tas. FVs differ in many
aspects of their replication from orthoretroviruses, such as the
human immunodeficiency viruses (HIV) (for a review [1]). Among
other peculiarities, the prototypic foamy virus (PFV) Gag
precursor lacks the landmarks of orthoretrovirus Gag polyproteins,
such as the major homology region and the Cys-His motif, and
rather displays unique distinctive features. The N-terminus of PFV
Gag harbors a coiled-coil motif that interacts with the light chain 8
of cellular dynein, allowing microtubule-dependent trafficking of
incoming viral particles towards the microtubule organizing center
[2]. Three short glycine-arginine-rich (GR) boxes were mapped in
the C-terminus of PFV Gag and have been implicated in viral
genomic RNA packaging, reverse transcription and viral particles
morphogenesis. In particular, the GRI domain binds to viral
nucleic acids in vitro [3], while the GRII box contains an essential
chromatin-binding sequence (CBS) that, by interacting with
histone proteins, allows tethering of incoming PFV pre-integration
complex to host chromosomes prior to viral genome integration
[4]. The GRII box was described as harboring also a nuclear
localization sequence (NLS) [5], a finding recently challenged [6].
Finally, the GRIII box can functionally complement the GRI box
and vice versa [7].
Protein transduction domains (PTDs) are short basic-rich
domains able to penetrate in nearly every cell type by directly
crossing the plasma membrane. Since they also allow the
simultaneous uptake of a wide array of conjugated cell-
impermeable biomolecules (polypeptides, polynucleotides, small
molecule drugs, 40-nm iron nanoparticles,…), PTDs have
emerged as powerful tools for the manipulation of cellular
functions at the protein level with a wide range of potential
applications in biological and medical research [8,9]. PTDs are
found in proteins of either cellular or viral origin such as the
Drosophila homeobox Antennapedia protein [10], the human
immunodeficiency virus type 1 transcriptional factor Tat [11,12]
and herpes simplex virus type 1 (HSV-1) tegument protein VP22
[13]. Synthetic homopolymers consisting of 6–8 basic residues
(arginine, lysine or ornitine) also endow with cell-penetrating
properties [14]. Initial studies reported that uptake is rapid and
receptor- and energy-independent [15]. These observations have
subsequently been attributed to accumulation of PTDs on the cell
surface via electrostatic interaction with negatively-charged
molecules and/or artefactual redistribution of internalized PTDs
following fixation [16,17,18,19]. Several recent reports suggested
that uptake might rely on both endocytic and nonendocytic
mechanisms, depending on several parameters such as the
concentration and the physiochemical properties of the PTD
and/or the associated cargo [20]. However, the internalization
mode of PTDs that would grant access to target sites in the
cytoplasm and/or the nucleus, thus yielding the biological effects,
still remains unclear and a matter of controversies.
Here, we report that the PFV Gag protein exhibits the ability to
spread from actively synthesizing cells to surrounding ones. By
analyzing the transcellular movement of Gag C-terminal trunca-
tion mutants, we mapped this property to the GRII box. The
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fused to either PFV Gag GRII box (GFP-GagGRII) or the C-
terminal domain of VP22 (GFP-VP22Cter), which harbors a
previously characterized PTD [13], was observed upon fixation
with methanol, but never in living cells or when cells were fixed
with glutaraldehyde, or treated with trichloroacetic acid (TCA)
known to precipitate soluble proteins prior to methanol fixation.
We also established that, when GFP-GagGRII or GFP-VP22Cter-
expressing cells were fixed with methanol in close contact to mock-
transfected ones, the latter became GFP-positive. Finally, we show
that expression of Gag GRII and full-length VP22, as fusion
proteins with the PFV Tas protein, in cells harboring the luciferase
gene under the control of the PFV LTR, induced luciferase
activity. On the contrary, transactivation was not detected when
cells expressing either GagGRII-Tas or VP22-Tas were co-cultured
with those harboring a plasmid encoding the PFV LTR, further
supporting the absence of intercellular spreading in vivo.W e
conclude that uptake and nuclear accumulation of PFV Gag in
naı ¨ve recipient cells represents an artificial diffusion event
occurring during cell fixation with subsequent nuclear retention
mediated by the CBS within the GRII box [4,7].
Results
PFV Gag displays different patterns of subcellular distribution,
being localized in the cytoplasm, the nucleus and the centrosome
in transfected and infected cells [5,21,22]. We also noticed that,
48 hours post-transfection of Cos6 cells with a full-length Gag-
expressing vector (Gag648), the entire cell monolayer stained
positive in an indirect immunofluorescence assay using anti-Gag
antibodies, while no signal was observed upon incubation of
mock-transfected cells. Intense Gag staining was detected both in
the cytoplasm and the nucleus in some cells that likely represent
the transfected ones, while it was strictly confined in the nucleus
in the rest of the cell culture (Fig. 1A). Similar observations were
made upon PFV Gag expression in other cell types, such as
hamster BHK21 or human U373MG cells (data not shown). By
studying the distribution of C-terminal truncated forms of Gag by
indirect immunofluorescence, we also found that the staining
pattern of Gag mutants lacking the GRIII box alone (Gag575)o r
together with the GRI box (Gag575del482–499) was similar to that of
the wild-type counterpart, with few intensely fluorescent cells
surrounded by numerous cells harboring nuclear staining
(Fig. 1B). In contrast, the expression of the Gag mutant missing
both the GRII and GRIII domains (Gag511) was restricted only to
some cells (fig. 1B). These results suggest that the PFV Gag region
harboring the GRII box is responsible for the intercellular
trafficking of the protein.
Spreading from actively synthesizing cells to neighboring ones is
a property attributed to PTD-carrying proteins. We therefore
asked whether PFV Gag harbors a PTD within the GRII box. To
answer this question, we expressed the GRII box fused to GFP
(GFP-GagGRII) into Cos6 cells, which were fixed with methanol
48 h later and analyzed for intrinsic fluorescence by microscopy.
While the parental GFP remained confined to expressing cells, we
found that the 23 amino acids peptide, spanning from aa 535 to aa
557 of PFV Gag, was sufficient to allow the extension of the GFP
signal from some transfected cells to the nucleus of surrounding
ones (Fig. 1C). We noticed also that the GFP-fusion protein
painted condensed chromosomes in cells undergoing mitosis
(Fig. 1C, red arrows), consistent with our previous findings that
the GRII box harbors a CBS [4].
As previously reported for other PTDs [23], intercellular
trafficking of GFP-GagGRII still occurred following treatment with
Brefeldin A (BFA), a reversible inhibitor of Golgi-mediated protein
secretion, or incubation at 4uC known to block endo/exocytosis
prior processing for fluorescence microscopy, or upon GFP-
GagGRII expression in gap junction-negative Neuro2A cells (data
not shown). Altogether these findings indicate that the GRII box of
PFV Gag displays the features of a PTD.
Figure 1. Intercellular spreading of full-length and C-terminal
deletion mutant PFV Gag proteins. A. Distribution of full-length
Gag (Gag648) in cells was analyzed by indirect immunofluorescence.
Forty-eight hours after transfection, cells were fixed with methanol,
labeled with anti-Gag antibodies followed by fluorescein-isothiocyanate
coupled secondary antibodies and visualized on a fluorescence
microscope. Nuclei were stained with DAPI. Original magnification
640. B. The intercellular trafficking of full-length and C-terminal
deletion mutant Gag proteins was followed as in A. In the illustration,
numbers mark the first and last amino acids which are preserved after
deletion. The glycin/arginine-(GR)-rich boxes are indicated by shaded
regions and their location and amino acids composition are represent-
ed below according to [31]. The plus sign corresponds to 100% of
positive cells, whereas the minus sign indicates that only transfected
cells are positive. C. Following methanol fixation, cells expressing GFP
or GFP-GagGRII were examined for intrinsic fluorescence. Nuclei are
stained with DAPI. Original magnification 640. Red arrows indicate a
cell undergoing mitosis.
doi:10.1371/journal.pone.0031108.g001
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visualized in methanol-fixed cells, we were unable to observe GFP
signal in the nucleus of recipient live cells (data not shown). Similar
results were previously reported for HSV-1 VP22 protein fused to
GFP [18,24,25,26,27]. In that case, failure to detect direct
fluorescence in recipient cells was initially attributed to levels of
the GFP-fusion protein below the detection limit or to unfolding
and/or quenching of GFP, which could be reverted upon
methanol fixation and rehydratation. However, subsequent studies
indicated that the internalization and nuclear accumulation of
VP22 observed in vitro might be artificial, resulting from protein
leakage upon cell fixation ([28]. To define whether translocation of
GFP-GagGRII from expressing cells to the nucleus of neighboring
ones is authentic or just a result of protein extraction during the
fixation step, we reproduced a previously designed experiment in
which a slide coated with cells expressing GFP fused to either PFV
GagGRII or the C-terminal region of VP22 (aa 100–301), which
harbors the PTD [13], was abutted head to head to a slide of
mock-transfected cells (Fig. 2A). The two slides were then fixed in
close contact with methanol and, next, examined by fluorescence
microscopy. As expected, 100% of GFP-GagGRII or GFP-
VP22Cter-transfected cells were found positive for GFP (Fig. 2B).
The entire mock-transfected monolayer fixed in proximity of GFP-
VP22Cter-expressing cells stained GFP-positive (Fig. 2B), as already
reported for wild-type VP22 [24]. More importantly, the same
observation was made in the case of the mock-transfected slide
fixed in contact with cells expressing GFP-GagGRII (Fig. 2B).
While fixing cellular structures, cold organic solvents (e.g.
methanol) concomitantly induce membrane permeabilization and
might therefore trigger differential extraction or redistribution of
soluble proteins or of proteins weakly or transiently associated with
cellular membranes, leading to an artificial localization. To
investigate further the intercellular trafficking properties of GFP-
GagGRII and GFP-VP22Cter, we compared their subcellular
localization after fixation of the transfected cell monolayer with
methanol, which fixes proteins by dehydration and precipitation,
or glutaraldehyde, which forms a stable covalent network through
intermolecular bridges between proteins [29]. In agreement with
published data [24], and with the results presented above (Fig. 1C),
when cells expressing GFP-GagGRII or GFP-VP22Cter were fixed
with methanol, secondary recipient cells displayed evident nuclear
fluorescence (Fig. 3, left panel). On the contrary, following
treatment with glutaraldehyde only a small number of GFP-
positive cells could be observed in either case (Fig. 3, middle
panel). Finally, to provide direct evidence that leaking occurs
during fixation, we reasoned that treatment of transfected cells
with TCA, which causes the quantitative precipitation of soluble
proteins, prior to methanol fixation, should not affect the
trafficking of proteins harboring genuine intercellular spreading
properties. As shown in figure 3 (right panel), TCA treatment
Figure 2. Extension of GFP fluorescence from cells expressing GFP-GagGRII or GFP-VP22Cter to recipient ones during fixation. A.
Representation of the experimental procedure followed: a slide coated with cells expressing GFP-GagGRII or GFP-VP22Cter was abutted head to head
to a slide of mock-transfected cells and, then, fixed in close contact. B. GFP-GagGRII- or GFP-VP22-expressing cells (transfected) and mock-transfected
cells (mock) were fixed with methanol in close contact and next visualized on a fluorescence microscope. Original magnification 640. Red arrows
indicate a cell undergoing mitosis.
doi:10.1371/journal.pone.0031108.g002
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those expressing either GFP-GagGRII or GFP-VP22Cter, without
affecting the intrinsic GFP signal. These results demonstrate that
protein precipitation before methanol fixation efficiently blocked
intercellular spreading of both GFP-fusion proteins and support
the hypothesis that extension of GFP fluorescence to recipient cells
adjacent to actively synthesizing ones is due to leakage during the
fixation procedure.
Failure to observe intercellular spreading of GFP-fusion
proteins might result from quenching of intrinsic fluorescence
by improper folding of GFP and/or by low protein levels. To
overcome these limitations we assessed such properties using a
sensitive reporter gene transcription assay based on the
transactivation of the PFV LTR by the viral Tas protein. We
therefore generated vectors encoding Gag GRII or full-length
VP22, which harbors a previously characterized PTD [13] and
was used here as positive control, fused in frame to the N-
terminus of Tas. Next, GagGRII-Tas, VP22-Tas or wild-type Tas
were used to transfect Cos6 cells together with a plasmid
encoding for the firefly luciferase gene under the control of the
PVF LTR (pLTR-Luc) or the corresponding promotor-less
counterpart (pGL3 basic). A plasmid harboring the renilla
luciferase driven by the cytomegalovirus immediate early
promoter (pRL-CMV) was also co-transfected and used for
normalization. Forty-eight hours later, transactivation of the viral
LTR was determined by measuring the luciferase activity. Either
GagGRII-Tas or VP22-Tas was able to induce reporter gene
expression, despite at a lower extent than wild-type Tas,
suggesting that the secondary structure of the fusion proteins
might influence their function (Table 1, direct). However, the
relative fold induction compared to the background signal
remained significant (Table 1). We next assessed whether the
Tas-fusion proteins could undergo intercellular transport by co-
culture experiments. Twenty-four hours after transfection, Cos6
cells expressing wild-type Tas or GagGRII-Tas or VP22-Tas were
mixed with cells bearing both the pLTR-Luc and the pRL-CMV
plasmids (ratio 1:1) and the luciferase activity was measured 48 h
later. None of these proteins was able to transactivate the PFV
LTR under these settings (Table 1, indirect). Changes in the
experimental conditions (time post-transfection, ratio of trans-
fected cells and time of co-culture) never lead to LTR
transactivation. These results further support the absence of
intercellular spreading of PFV Gag GRII and VP22 in vivo.
Discussion
In the past decade, protein transduction has emerged as a
promising approach for the direct intracellular delivery of a wide
array of biologically relevant molecules in applications ranging
from basic research on cell functions to the development of
therapeutics for the treatment of human diseases [8,9]. Despite the
field suffered from the controversies about the efficacy of PTD-
mediated delivery [16,17,18,19] and several drawbacks such as
poor specificity and endosomal entrapment of PTD-cargo are
unsolved, the promise of high yield of delivery, low toxicity,
versatility of cargo and wide range of target cell types still
stimulates the search for novel peptides with transduction
properties [30].
Figure 3. The fixation procedure influences the intercellular spreading of GFP-GagGRII and GFP-VP22. Cells expressing GFP-GagGRII or
GFP-VP22 were fixed with methanol, glutaraldehyde or treated with TCA before fixation with methanol, as indicated. Cells were then analyzed for
intrinsic fluorescence. Original magnification 640.
doi:10.1371/journal.pone.0031108.g003
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displays transcellular movement [31] and decided to investigate
this property further. Here, we show that intercellular spreading of
Gag can be attributed to the GRII box. Upon fixation with
methanol of a cell monolayer transfected with a plasmid encoding
for GFP-GagGRII, we found that virtually every cell exhibited a
bright nuclear fluorescence, while spreading was not observed in
live cells. Similar results have been reported for HSV-1 VP22,
which uptake has already been suggested to be a post-fixation
artifact [28]. In that case, the protein was shown to adhere to the
cell surface, likely via its PTD, and to penetrate in the cytoplasm
and/or the nucleus following loss of membrane integrity upon
fixation [19,28]. Persistent accumulation in the nucleus following
import was ascribed to the affinity of VP22 for chromatin
[32,33,34]. Likewise, the PFV Gag GRII box harbors a CBS that
mediates tethering to cell chromosomes [4], explaining its
enrichment in the nucleus of secondary recipient cells. Of note,
we consistently observed that GFP fused to either GagGRII or
VP22 painted mitotic chromosomes (Fig. 1C and 2B).
Fixation prior to microscopy studies is critical to preserve
cellular structures and proteins distribution. Thus an inappropriate
procedure might yield factitious observations due to redistribution
or leakage of soluble protein from permeabilized cells [35].
Noteworthy, while control experiments typically address the
specificity of the antibodies, little care is frequently paid on the
choice of the fixation agent, which is often based on routine
practice rather than on systematic comparison of different
methods. By using different fixation procedures, we established
that spreading and nuclear localization of the PFV Gag is due to
artificial transport occurring during cell fixation, as already
observed in the case of VP22 [19,28]. More importantly, by
showing that fluorescence is strictly confined to PFV GagGRII-o r
HSV-1 VP22-expressing cells when soluble proteins are precipi-
tated by TCA treatment prior to methanol fixation in order to
preserve faithful localization prior to membrane permeabilization,
our results indicate that intercellular spreading is due to post-
fixation extraction of soluble proteins. This conclusion is further
supported by the finding that expression of GagGRII or full-length
VP22 as fusion protein with Tas is not sufficient to allow the
delivery of the viral transactivator into co-cultured cells harboring
the luciferase gene driven by the PFV LTR, as indicated by
absence of reporter gene expression.
Although it cannot be excluded that a small amount of protein
might translocate across the cell membrane, and/or that a cargo
fused to the PTD might affect its structure thus interfering with the
delivery of the complex, several studies including the present
strongly point out that caution should be used before defining a
novel PTD. Additionally, it is currently clear that fluorescence
microscopy studies on fixed cells, an accessible and widely used
technique to determine the subcellular distribution of a protein, is
not a technique suited to address the genuine transcellular
properties of such domains.
Materials and Methods
Plasmid constructions
Gag expression plasmids, corresponding to the entire Gag ORF
(Gag648) and C-terminal deletion mutants were constructed as
previously described [31]. To produce the GFP-GagGRII express-
ing vector, we generated a duplex encoding for the GRII box (aa
535–557 of PFV Gag) flanked by cohesive ends by annealing of
specific complementary oligonucleotides. The annealing reaction
mixture (50 ml) containing 20 ml of each oligonucleotide (50 mM),
25 mM Tris-HCl pH 8, 10 mM MgCl2, was heated at 95uC for
5 min and then cooled to room temperature. Five microliters of
this mix were used for ligation with 200 ng of pEGFP-C1 digested
with EcoRI-BamHI. GFP-VP22C-ter containing the C-terminal
region of VP22 (aa 100 to 301) was obtained by inserting the
BspEI-BamHI fragment of pVP22/Myc-His (Invitrogen) into
pEGFP-C1. To generate a Tas-fusion protein expressing vector
(pSV-Tasbx), the BglII and XhoI restriction sites were inserted in
the 59 end of the tas ORF into the pSV-Tas plasmid [36] using the
QuickChange mutagenesis kit (Stratagene). A double strand
oligonucleotide encoding for the GRII box with an ATG initiator
codon and flanked by cohesive ends, was generated by annealing
of single-stranded complementary of nucleotides as described
above and, next, introduced into pSV-Tasbx, yielding the
GagGRII-Tas vector. The VP22-Tas plasmid was generated upon
insertion of a PCR product encoding the entire VP22 ORF into
pSV-Tasbx. To generate the pLTR-Luc vector, the PFV LTR
sequence was extracted from pHFV13, which encodes the entire
proviral genome of HFV, with BamHI and HindIII and was
inserted in the promoterless pGL3basic vector upstream of the
firefly luciferase gene (Promega). The identity of recombinant
clones was verified by DNA sequencing.
Cell culture
Cells were grown in Dulbecco’s modified Eagle medium
supplemented with 5% fetal calf serum, 2 mM L-glutamine,
25 mM Hepes and antibiotics (penicillin/streptomycin), at 37uC,
5% CO2. Cos6, a SV40-transformed African green monkey
kidney cell line, was purchased from ATCC.
Transient transfection and luciferase activity assay
Cells (10E5 cells per well) were seeded into 6-well plates.
Transfections were performed using Lipofectin (Gibco-BRL) with
1 mg of DNA plasmid, as specified by the manufacturer.
For the transactivation experiments, Cos6 cells were co-
transfected with the pGL3basic or pLTR-Luc and pRL-CMV,
which encodes the renilla luciferase under the control of the
cytomegalovirus immediate-early promoter and is used for
normalization, together with vectors encoding PFV GagGRII-Tas
or VP22-Tas or wild-type Tas. Alternatively, cells harboring
pLTR-Luc and pRL-CMV were mixed with those expressing PFV
GagGRII-Tas or VP22-Tas or wild-type Tas (ration 1:1), 24 h after
transfection. The appropriate empty vector was used as negative
control. After 48 h, cell supernatants were analyzed for luciferase
activity in duplicate using the Dual-Luciferase Reporter Assay
Table 1. Lucifarase activity following transactivation of the
PFV LTR.
Fold increase
constructs WT Tas GRII-Tas VP22-Tas
pGL3basic 0.5 1 1
LTR-Luc direct 45 13 8
LTR-Luc indirect 1 1 0.1
Activation of the luciferase reporter gene was measured following expression of
wild-type Tas or GagGRII-Tas or VP22-Tas in Cos6 cells harboring the pLTR-Luc/
pRL-CMV plasmids (direct). The normalized luciferase activity measured in cells
transfected with the appropriate empty vector was set to 1. Alternatively, cells
expressing wild-type Tas or GagGRII-Tas or VP22-Tas were co-cultured with
recipient cells harboring the pLTR-Luc/pRL-CMV plasmids (indirect). Values are
representative of three independent transfection experiments performed in
duplicate.
doi:10.1371/journal.pone.0031108.t001
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luminometer, and a Microlite 1 flat-bottom microtiter plate
(Thermo Labsystems).
Fluorescence microscopy
Forty-eight hours after transfection, cells were washed twice
with PBS and were prepared for monitoring the GFP fluorescence
according to different treatment conditions: (i) Cells were fixed
with 100% methanol at room temperature (RT) for 15 min and
then rinsed with PBS. (ii) Cells were fixed with 1% glutaraldehyde
1 h at RT. (iii) Cells were pretreated with 5% tri-chloro-acetic acid
(TCA) overnight at 4uC before methanol. For indirect immuno-
fluorescence, Gag proteins were detected with rabbit polyclonal
anti-Gag antiserum and revealed with secondary fluorescein
isothiocyanate-coupled antibodies. Following incubation with
49,6-diamidino-2-phenylindole (DAPI) (250 ng/ml) to stain the
nucleus, cells were embedded in Mowiol (Calbiochem) and were
examined with a Bio-Rad MRC-1024 confocal imaging system
(Hertforshire, United Kingdom) and an inverted Diaphot 300
Nikon microscope. Images were collected with an oil immersion
objective (406, NA I0.4 plan Apochromat).
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